Mr. Zou graduated from China Agricultural University, he is a young member of the Professional Committee of Drug Toxicology and Safety Evaluation of the Chinese Society of Toxicology. He gained the qualification certification of Chinese toxicologists, and has been engaged in preclinical safety evaluation of medicines for more than 15 years. He is mainly engaged in the safety evaluation of new medicines, familiar with domestic and international regulations and guidelines, and has been subject to on-site inspections by USFDA and CFDA for many times. As a project leader, he has been responsible for the safety evaluation of more than 300 medicines and more than 600 projects. Several projects have been successfully submitted to domestic and foreign countries and entered into clinical trials. He has evaluated many novel medicines, including small molecules (mainly chemical 1.1) and large molecules (novel biologics, bispecific antibodies, ADCs, oligonucleotides), etc. He has published more than 10 professional papers.
Jiajie Zou
